Zepbound, the weight-loss version of Tirzepatide, added $2.31 billion in Q1 sales, bringing the total to $6.15 billion, making it Semaglutides biggest rival and a strong candidate for future top drug status
For example: A low-calorie diet helps create a calorie deficit, while exercise burns additional calories
31, and its unknown what patients will pay in 2024 and beyond for the drug
We call it a side effect, but truly that is how the drug could work by making you feel you dont want to eat, Li said
These include: The severity of B12 deficiency The presence of underlying health conditions Genetic variations affecting B12 metabolism The duration of supplementation Knowing these factors helps tailor the dose to meet individual needs, ensuring the best results
Market Breakup by Route of Administration 7.1